Impact of Long-term Ivacaftor on Lung Function in CF with Gating Mutations
发布者：Unknown
·发布于: 2025-12-13
A discussion on the efficacy of long-term Ivacaftor treatment regarding the rate of lung function decline in individuals with cystic fibrosis and CFTR-gating mutations, specifically comparing outcomes against those not receiving CFTR modulator therapy.